So exciting data! Love the interview. #microbiome #guthealth #ada2022 lnkd.in/dbQuXW2N

If you're at #ADA2022, come check out our cool work on the OSH-induced #microbiome from Gelesis and our collaborators. I'm at poster 1392-p. ->Maria Rescigno interview: youtu.be/AsmUo7lnQbs Thanks to all involved! Antonio Gil-Gomez Alessandra Silvestri Elaine Chiquette @YishaiZohar

Come and see our poster at #ada2022 on the use of person-first language in scientific literature. It tells us that we are far from #stigmafree for both epidemic #obesity and #diabetes. Weight stigma impacts overall health and efficacy of interventions..…lnkd.in/d9aseygS

Today at #ADA2022 we’re presenting new data suggesting that our superabsorbent hydrogel causes changes to the #microbiota leading to #weightloss and improvements in glucose tolerance & insulin sensitivity. Read more: bwnews.pr/3xgZggF #microbiome #obesity

So much interesting stuff at #ADA2022. Take a look at this work on #Microbiome and the Gelesis hydrogel technology.

New research at #ADA2022 tells us researchers are adopting #PersonFirst language for #obesity. The pace is quickening, but we have miles to go. HT: Damian Bialonczyk Jane K. Dickinson Elaine Chiquette @KellyClose Joe Nadglowski @matthewgarza98 conscienhealth.org/2022/06/regard…

We are happy to share that our partner @Ro has placed a pre-paid order of $15M for Plenity following the success of our national media campaign last qrter, with a new record high for new Rx requests. This is in addition to previous pre-orders totaling $40M bwnews.pr/3bgWrUx

See what Forbes had to say about @Plenity:

If you're at Microbiome Mvmt Drug Development conference, come see how Gelesis oral superabsorbent hydrogels impact the Microbiome and metabolic health mice. Thanks to our wonderful collaborators in Milan Alessandra Silvestri Maria Rescigno Antonio Gil-Gomez #weightloss

Gelesis proudly supports the efforts of Ted Kyle as a long time advocate against the stigma people with obesity face. Obesity is a complex, chronic, relapsing disease impacting millions of Americans. Attaching a stigma to obesity helps no one.

Today we announced our second quarter results. We are excited about the progress we are making in delivering care to people struggling with excess weight. For details and to learn more about our commitment to obesity care visit: businesswire.com/news/home/2022…

Today we are presenting our latest clinical data from the LIGHT-UP Study at the International Congress of Endocrinology. The data suggests our oral hydrogel may improve insulin sensitivity and favorably impact metabolic syndrome. To learn more visit: businesswire.com/news/home/2022…

Are you at Obesity Week #OW2022? Are you interested in Akkermansia and the #microbiome? Of course you are! Be sure to stop by my poster today where I will be sharing new data on #Akkermansia and oral superabsorbent hydrogels.

Today we shared our Q3 financials and our vision for how to make Plenity more accessible to the millions of people struggling with excess weight. Read more about the business and our intention to change the classification of Plenity to OTC (non-Rx): bit.ly/3O4u4rW

We are proud to share w/ @Ro the lrgst published cohort of 20k DTC telehealth users seeking prescriptive weight management. The bottom line: Patients with preobesity are undertreated and actively seeking new weight management options. formative.jmir.org/2023/1/e40062 #obesity

Approximately one-third of the people in our sample had preobesity (ie, BMI 25-30 kg/m2) when they first initiated treatment with Plenity, and most patients in this cohort reported no weight-related comorbidities

Almost all patients (~99%) in our large cohort reported previously attempting at least one weight loss method before Plenity. Moreover, ~30% of patients had previously tried an Rx weight loss drug before Plenity.

Proud to present at #ADA2023 showing real-world effectiveness of Plenity across 894 people. Responders lost ~9% over 6 months. Plenity could help w/ ongoing need in #weightmanagement, including for patients at lower BMI range of #overweight / #obesity: bwnews.pr/3CNDTpp

Today Cell Reports Medicine: #weightloss from our OSH trtment was not only bc of space-occupying properties; mechanical composition/structure of material may have benefits for #gut & #metabolichealth. OSH notably induced endogenous #GLP1, reduced #insulin resistance bit.ly/46UGVW0